Christopher Larson is the Vice President of Quality Control at Castle Creek Biosciences, Inc., bringing over 25 years of experience in the biotechnology industry. His expertise spans GMP testing, research and development, and clinical laboratory operations, supporting products from pre-clinical stages through to commercialization.
Prior to joining Castle Creek, Mr. Larson served as Senior Director of GMP Testing at SK Pharmteco’s North American Cell and Gene Therapy facility. He has also held laboratory leadership roles at Endo Pharmaceuticals and WuXi AppTec. Earlier in his career, he was part of the team that developed the first FDA-cleared in vitro diagnostic blood assay for detecting circulating tumor cells. He began his career at Jefferson Hospital, supporting cell processing and specialized assays for the Bone Marrow Transplant Department.
Mr. Larson holds a bachelor’s degree in Medical Technology from the University of Delaware and a master’s degree in Cell Biology and Biotechnology from the University of the Sciences in Philadelphia.
